One thing wrong with any genmod dna is that the gene
splice happens out of order all the time, with completely
untested results.
Another serious problem with any genmod dna is that the
cabbage mozaic virus stripped of its protein sheath is no
longer identified to the human immune system by its
protein sheath, and genmod material is contaminated
with the gene splice carrier, which may be the cabbage
mozaic virus.
Another gene splice carrier, a modified soil bacteria,
could act like mycoplasma fermentans, one of the
Gulfwar illnesses, or simply as a bacteria or mycoplasma
that does act on humans since it has been modified.
Modifying live virus could result in the crossover to
humans which we have seen no proof of with the
non-genmod virus.
We have read these things about genmod material
here in the last week or two.
-Bob
Linda Minor wrote:
U.S. Team Will Test Live-Virus Bird Flu Vaccine
www.sandersresearch.com
The
Heron's Latest Catch
December
19, 2005
U.S.
Team Will Test Live-Virus Bird Flu Vaccine
Healthcentral.com
Researchers at the U.S. National Institutes of Health will soon recruit
30 human volunteers to test the effectiveness of a vaccine containing a
live but weakened form of the H5N1 bird flu virus. According to the
Associated Press, this flu shot would differ from the standard
influenza vaccines distributed each year because it contains live
rather than killed virus — potentially rendering it more powerful in
inducing an immune response.
The live virus used in the upcoming trial will be genetically altered,
however, so that it won't make people sick. Its hoped that the new
vaccine will prime the volunteer's immune systems to recognize a more
deadly strain of H5N1 if and when it appears.
Up till now, avian flu outbreaks have been mostly confined to bird
populations, although experts believe 70 people have died worldwide
from H5N1 infection after picking up the virus from poultry. The real
fear, experts say, is that the pathogen will mutate to allow for
human-to-human transmission. In that case, a pandemic could kill
millions worldwide.
That's why a potentially potent vaccine containing live virus is "a
great, great idea," flu expert Dr. John Treanor of the University of
Rochester told the AP. "In theory, a live-virus vaccine might actually
work better [than a killed-virus shot]," he said. "We don't know that
because we've never tried one before."
Tests this summer using a vaccine made with another, less dangerous
strain (H9N2), showed the method might be safe and effective. Lead
researcher Dr. Kanta Subbarao told the AP that the trial involving the
weakened H5N1 strain is set to begin in April, pending U.S. Food and
Drug Administration approval.
Complete archives at http://www.sitbot.net/
Please let us stay on topic and be civil.
OM
SPONSORED LINKS
YAHOO! GROUPS LINKS
|
